Comparing chair-based and standard exercise programs for people with COPD
Comparison of the Effectiveness of Chair-based and Standard Exercise Programs in People With COPD
NA · Istanbul Medipol University Hospital · NCT06201299
This study is testing whether a chair-based exercise program is just as helpful as a standard exercise program for people with COPD who are starting pulmonary rehabilitation.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 64 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Istanbul Medipol University Hospital (other) |
| Locations | 1 site (Istanbul, Zeytinburnu) |
| Trial ID | NCT06201299 on ClinicalTrials.gov |
What this trial studies
This study involves patients diagnosed with COPD who are referred to pulmonary rehabilitation. Participants will be randomly assigned to either a standard exercise program group or a chair-based exercise program group. Both groups will receive initial training in the hospital and will perform exercises at home using provided videos, with additional online training sessions with a physiotherapist. The program lasts for 8 weeks, with exercises conducted five days a week.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-75 with a clinical diagnosis of COPD and stable health status.
Not a fit: Patients with severe comorbidities or those who have recently participated in a pulmonary rehabilitation program may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve exercise tolerance and quality of life for patients with COPD.
How similar studies have performed: Previous studies have shown positive outcomes with exercise interventions in COPD, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being between the ages of 18-75 years * Having a diagnosis of COPD diagnosed according to clinical diagnostic criteria according to the American Thoracic and European Respiratory Societies (ATS-ERS). * Presence of dyspnea on exertion * Stable clinical status at inclusion without infection or exacerbation in the previous 4 weeks \*Having smart phone usage skills Exclusion Criteria: * Patients with severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases and requiring high-flow oxygen therapy (˃ 3-4 L\\min). * A history of exertional syncope or the presence of any comorbidities (such as severe orthopedic or neurological deficits or unstable heart disease) that preclude exercise training. * Having participated in a pulmonary rehabilitation program within the last 12 months.
Where this trial is running
Istanbul, Zeytinburnu
- Yedikule Chest Disease Hospital — Istanbul, Zeytinburnu, Turkey (Türkiye) (RECRUITING)
Study contacts
- Study coordinator: ESRA PEHLİVAN
- Email: fztesrakambur@yahoo.com
- Phone: 09050585279
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: COPD, Pulmonary Rehabilitation, Exercise